European Pharmaceutical Review

JULY 5, 2023

The long-awaited PDA TR 43 report provides an approach to a quality decision-making process and represents best practices for the identification and classification of visual nonconformities for (empty) glass containers as pharmaceutical product packaging.

Manufacturing 73

Manufacturing Pharmaceutical manufacturing Pharmaceutical products Consulting 73

European Pharmaceutical Review

FEBRUARY 22, 2023

Key features of the PDA TR 90 report The document addresses the evolution of contamination control principles towards a holistic approach. Dr Madina Karimova, Quality Assurance Manager at Sanofi shared her opinion on PDA’s TR 90 report, highlighting parts she found valuable.

Pharmaceutical manufacturing 87

Pharmaceutical manufacturing Manufacturing Pharmaceutical Management 87

Pharmacy Times

SEPTEMBER 20, 2022

Researchers will submit a new drug application to the FDA after a phase 3 trial found that iDose TR slow- and fast-release models met their primary endpoint in patients with glaucoma.

FDA 49

FDA Patients 49

World of DTC Marketing

APRIL 20, 2021

After a year of pandemic-delayed medical tr eatments, doctors are seeing more cases of advanced illnesses. Last month I hit 80,000 readers when accounting for email, social media, and direct traffic. I love the industry, and although I want to see some changes, I know there are many good people trying every day to make it happen.

Pharma 253

Pharma Doctors Physicians Specialization 253

Pharma Pathway

NOVEMBER 3, 2022

Executive/ Tr. Company Name: Lee Pharma Limited. Departments: Production/ AR&D/ R&D/ QC/ QA/ HR/ ETP. Designation: Chemist/ Sr. Chemist/ Research Associate / Sr. Research Associate/ Executive/ Sr. Qualification: B.Sc/M.Sc/ M.Sc/ MBA/ Intermediate/ SSC. Experience : 0 to 07 years. Location: Unit-I, Hyderabad.

Pharma 52

Pharma Manufacturing 52

European Pharmaceutical Review

OCTOBER 11, 2023

Dr Jennifer Wargo, Professor of Genomic Medicine and Surgical Oncology and Director of PRIME-TR at MD Anderson, remarked that she is optimistic this agreement will accelerate the development and manufacture of more microbiome-based therapies for patients.

Manufacturing 77

Manufacturing Medicine Patients Leads 77

Pharmaceutical Technology

FEBRUARY 2, 2023

It combines the expertise and capabilities of Platform for Innovative Microbiome and Translational Research (PRIME-TR) of MD Anderson with the ACT (anaerobic co-culture technology) platform of Federation Bio.

Manufacturing 52

Manufacturing Patients Leads Pharmaceutical 52